Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hengyang
Clinical trial register · China

Clinical Trials in Hengyang, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Beijing 5586 Shanghai 3885 Guangzhou 3356 Hangzhou 1825 Wuhan 1342
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
The First Affiliated Hospital of University of South China3 Nanfang Hospital, Southern Medical University3 Eli Lilly and Company2 AstraZeneca2 Hunan Cancer Hospital1 University of South China1 RenJi Hospital1 Sun Yat-sen University1 Cloudbreak Therapeutics, LLC1 Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.1 Loxo Oncology, Inc.1 The Third Xiangya Hospital of Central South University1 Mabwell (Shanghai) Bioscience Co., Ltd.1 Synermore Biologics (Suzhou) Co., Ltd.1 Xiangya Hospital of Central South University1 Shanghai Zhongshan Hospital1 Astellas Pharma Global Development, Inc.1 Zhejiang Yangli Pharmaceutical Technology Co., Ltd.1 Zhongming Qiu1 Alexion Pharmaceuticals, Inc.1 Guangzhou Patronus Biotech Co., Ltd.1
Site location
Beijing5586 Shanghai3885 Guangzhou3356 Hangzhou1825 Wuhan1342 Chengdu1310 Nanjing1213 Changsha1159 Chongqing1081 Fuzhou1043 Tianjin937 Zhengzhou930 Hefei901 Jinan788 Changchun640 Shenzhen582 Harbin549 Nanchang445 Xi'an442 Nanning439 Suzhou427 Shenyang407 Xiamen392 Shijiazhuang348 Lanzhou272 Bengbu218 Wenzhou189 Kunming187 Guiyang182 Qingdao171 Luoyang156 Ningbo152 Taiyuan148 Foshan144 Dalian135 Xuzhou134 Haikou124 Changzhou124 Dongguan106 Shantou101 Nantong99 Hong Kong98 Wuhu92 Wuxi84 Huizhou83 Baoding83 Anyang83 Baotou82 Zhuhai79 Guangdong76 Xi’an71 Liuzhou70 Cangzhou63 Zhongshan60 Hohhot59 Ganzhou57 Xinxiang57 Taizhou55 Yangzhou55 Jiangmen54 Guilin54 Ürümqi52 Guanzhou51 Yiwu50 Zhanjiang48 Zhejiang47 Yinchuan47 Linyi47 Meizhou46 Fuyang46 Nanyang45 Zunyi45 Zhangzhou44 Quanzhou43 Jinhua43 Hanzhou42 Changde42 Lishui42 Huzhou41 Huai'an39 Langfang38 Jining37 Jiaxing37 Fujian36 Tangshan35 Jilin City34 Xiangyang32 Hunan31 Xining31 Henan31 Binzhou30 Daqing30 Kaifeng29 Shandong28 Yantai28 Changzhi28 Chifeng28 Yichang27 Hengyang27 Chengde27 Xingtai26 Sichuan25 Jingzhou25 Xianyang24 Hubei24 Weifang23 Mianyang23 Shiyan23 Wuzhou22 Hebei22 Haerbin21 Luzhou21 Lianyungang21 Wuwei21 Jiamusi20 Shaoguan19 Nanchong19 Deyang19 Bozhou18 Zhenjiang18 Liaocheng18 Anqing18 Chenzhou18 Putian18 Shanxi18 Yancheng18 Shaoxing17 Handan16 Qingyuan16 Quzhou16 Zibo15 Yulin15 Qinhuangdao15 Shangqiu15 Chizhou15 Guangxi14 Xian14 Maoming14 Pingxiang14 Luoyang Shi14 Haidian13 Guizhou13 Heilongjiang13 Zhenzhou12 Xiangtan12 Dongyang12 Jiaozuo12 Shengyang12 Ha’erbin12 Linfen11 Nanjin11 Kunshan11 Chaoyang11 Huaian11 Yan’an11 Ma’anshan11 Suqian11 Beijin11 Guandong11 Huanggang10 Jiujiang10 Qionghai10 Zhuzhou10 Ankang10 Jieyang10 Longyan10 Heyuan10 Tianjing10 Baise City10 Guigang9 Tongling9 Weinan9 Chuzhou9 Hanzhong9 Neijiang9 Liupanshui8 Heze8 Yueyang8 Zigong8 Jiangxi8 Linhai8 Zhaoqing8 Huaihua8 Shaoyang8 Tai’an8 Qinzhou8 Zhoukou8 Dezhou7 Dongying7 Xuchang7 Hengshui7 Shenzhen Shi7 Ch’ang-ch’un7 Zhangjiakou7 Anhui7 Jinjiang7 Sanming7 Fuzhou Fujian7 Hainan7 Cheng Du Shi7 Lu'an7 Yibin7 Sanya7 Dali7 Huainan7 Baoji7 Xicheng7 Kashgar6 Puyang6 Huangshi6 Suining6 Jinzhou6 Meihekou6 Luohe6 Xuancheng6 Chaoyang District6 Zhoushan6 Kaili6 China6 Yuncheng6 Shanghai Shi6 Naning6 Xuhui6 Dazhou6 Macao5 Enshi5 Anshan5 Yuzhong5 Yixing5 Datong5 Yuhuan5 Dongcheng5 Panjin5 Sanmenxia5 Qianjiang5 Shihezi5 Wanzhou5 Changping5 Jiazhuang5 Mudanjiang5 Haidian District5 Tongliao5 Lanxi5 Bijie5 Zhumadian5 Wenling4 Jiangsu4 Weihai4 Xianning4 Taian4 Benxi4 Qinghai4 Huangshan City4 Ya'an4 Ningde4 Hezhou4 Suzhu4 Jiangyin4 Ji'nan4 Qiqihar4 Chaohu4 Pudong4 Changshu4 Jingdezhen4 Yongzhou4 Multiple Locations4 Jiuquan4 Huangpu4 Gaozhou4 Anning4 Chendu4 Yunnan3 Aksu3 Yanan3 Beijingcun3 Shanwei3 Shunde3 Zhujiang3 Changsha Shi3 Rizhao3 Shapingba3 Bishan3 Dongwan3 Anshun3 Minhang District3 Gansu3 Binhai3 Huaibei3 Chongqicun3 Dengzhou3 Yangpu3 Shang'ai3 Loudi3 Leshan3 Ji’an3 Xingyi3 Guankou3 Fushun3 Fuxin3 Guangdong Province3 Hebi3 Yangjiang3 Neimeng3 Jiyuan3 Zhangjiang3 Lhasa3 Weihui3 Beihai3 Xinjiang3 Yunfu3 Linqing2 Maanshan2 Meishan2 Liangyugang2 Ninghai2 Fuling2 Hechuan2 Yichang Shi2 Guiping2 Karamay2 Taipei2 Ningxia2 Xigazê2 Inner Mongolia2 Pingdingshan2 Yichun2 Herbin2 Gongshu District2 Chongqi2 Tongzhou2 Meicheng2 Tongren2 Baotou Shi2 Xuhui District2 Shatin2 Changzhou Shi2 Hechi2 Jishou2 Huayuan2 Dangyang2 Yixingcun2 Dandong2 Zaozhuang2 Yueqing2 Chibi2 Jingjiang2 Suizhou2 Xiaogan2 Jing’an2 Haozhou2 Dingxi2 Changle2 Macau2 Panlong2 Guli2 Many Locations2 Yisa2 Shanhai2 Lincang2 Xicheng District2 Fengtai2 Jincheng2 Rui’an2 Yiyang2 Xinyang2 Danyang2 Qiandongnan Miao and Dong Autonomous Prefecture2 Qiannan2 Jiaxin2 Xiantao2 Tianshui2 Jinzhong2 Guangyuan2 Nan'ning2 Taiwan2 Qujing2 Taihe Chengguanzhen2 Anxi2 Changlexi2 Hetian1 Yangcheng1 Chengdoucun1 Feicheng1 Jingmen1 Chengdu, Sichuan1 Chancheng District1 Liwan District1 North Street1 Nanshan District1 Luoyan1 Hami1 Liu‘an1 Xianmencun1 Zhenngzhou1 Xichengqu Beijing1 Beijing Sheng1 Gunan1 Jiangjin1 Wulong1 Sanhe1 Ruyang1 Qidong1 Xiangya1 Tongji1 Wujin District1 Guangong Apt/Yuncheng1 Chaozhou1 Jimsar1 Luopu1 Yining1 Tainan1 Taoyuan1 Changchuan1 Guangzhusi1 Zhuozhou1 Fyzhou1 Qingyang1 Lingchuan1 Xing’an1 Daming1 Dingxing1 Zhengding1 Wenquan1 Shangluo1 Ji'an1 Dexing1 Wanzai1 Linxia1 Siping1 Wuhai1 Dongguan Shi1 Pinggu1 Xi'an, China1 Chongli1 Beijing, China1 Beijeing1 Deyang Shi1 Foshan Shi1 Taishing1 Xiameng1 Tongchuan1 Hexi District, Tianjin1 Daping1 Pu'er1 Ezhou1 Chengxiang1 Zheng'zhou1 Heihe1 Lianyuan1 Yongji1 Hongcun1 XiAn1 Zhangjiagang1 Nayong1 Yuzhong District1 Shenyany1 Hengzhou1 Duyun1 Ordos1 Chian1 Guanghzou1 Heifei1 Maoming Shi1 Tiyuan1 Nanzhang Chengguanzhen1 Chongzuo1 Laibin1 Pinghu1 Guangxi Zhuang Autonomous Region1 Fulingqu1 Siming1 Changning1 Lingbao1 Fengcheng1 Beijjing1 Zhangye1 Yizheng1 Junxian1 Pingdu1 Zouping1 Huozhou1 Jiexiu1 Hegang1 Shuangyashan1 Suihua1 Louxing District1 Guang’an1 Dongfang1 Minhang1 Shancheng1 Yangzhou SHI1 Cangzhou Shi1 Chongging1 Linquan County1 Guangdong Province Guangzhou City1 Fenyang1 Jiayuguan1 Liangshan1 Ziyang1 Shenzhencun1 Zhaotong1 Yingtan1 Xiangshan1 Liaoyou1 Taihe1 Zhangping1 Longzhou1 Bingjie1 Gannan1 Hexi District1 Jixi1 Yangchun1 Sanjiaocheng1 Chuangchun1 Daozhen Klau and Hmong Autonomous County in Zun'yi1 Qiandongnan Miao and Dong Autonomous Region1 Jina1 Chang’an1 Cili1 Lanshan1 Leiyang1 Pingjiang1 Yangzhong1 Tianmen1 XI 'an City, Shaanxi Province1 Laizhou1 Qinhuangdao Shi1 Linyi Shi1 Linping1 Qingzhen1 Ningxiang1 Jianli City, Jingzhou City1 Jingxi1 Tengzhou Town1 Xiangyang City, Hubei Province1 Changcun1 Chongoing1 Zunhua1 Mengzhou1 Nanle1 Pizhou1 Changshang1 Yanji1 Gu'ang'zhou1 Ulanhot1 Jihan1 Hubei Sheng1 Wenshan Zhuang and Miao Autonomous Prefecture1 Anhui Sheng1 Zhongshan Town1 Yushu1 Sichuan Chengdu1 Jiangse1 Binzhou Shi1 Changhua1 Wuhang1 Gengma County1 Xian City1 Baiyin1 Xinle1 Yunlin1 Bayan Nur1 Anning, Yunnan - South Region1 Beijing, Beijing1 Cangzhou, Hebei - North Region1 Caoxian County, Shandong Province1 Changzhou, Jiangsu Province1 Chengdu, Sichuan Province1 Chongqing, Chongqing1 Chongqing, Sichuan Province1 Wu’an1 Fuding1 Zhuji1 Kaiping1 Heping1 GuiZhou1 HuBei1 HuNan1 Baoshan1 Tanjing1 Haizhu1 Shijia Zhuang1 Jiancheng1 Fuqing1 Nanping1 Tanjin1 Jiading1 Shushan1 Lanfang1 Chuxiong1 Puer1 Wenshan1 Hengshui Shi1 Dazhu1 Dingzhou1 Shang’ai1 Feixian1 Gulin1 Hanyang1 Wannan1 Beiliu1 Guidong1 Xizang1 Gongyi1 Fu'zhou1 Wuha1 Tacheng1 Longgang1 Jinghong1 Zhengjiang1 Puning1 Hongkou1 Heifi1 Changshan1 Najing1 Gui'lin1 Hshijiazhuang1 Wuhou District1 Changshashi1 Shanhu1 Xiangyun1 Xinzheng1 Hangzou1 Yongcheng1 Jining Shi1
All 625 locations
Target enrolment
to

Trials with a site in Hengyang

27 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
AstraZeneca
Not applicable
540
Chengdu, Chifeng, Dongyang, Hefei, Hengyang, Heze, Jiaxing, Langfang
2026-09-05
Not yet open
A Phase II Study of VB19055 in Uncontrolled or Resistant Hypertension
NCT07833098Hypertension, Resistant Hypertension, Uncontrolled Hypertension
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
Phase 2
240
Baotou, Beijing, Changsha, Chengdu, Chongqing, Daqing, Hebei, Hengyang
2026-09
Recruiting
Eli Lilly and Company
Phase 2
531
Binzhou, Chengdu, Guangzhou, Hangzhou, Hengyang, Huizhou, Huzhou, Meihekou
2026-05-06
Recruiting
Eli Lilly and Company
Phase 2
342
Binzhou, Chengdu, Guangzhou, Hangzhou, Hengyang, Huizhou, Huzhou, Meihekou
2026-04-29
Not yet open
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
Phase 2
250
Hefei, Nanning, Haikou, Jingzhou, Wuhan, Changsha, Hengyang, Nanchang
2026-03-23
Recruiting
Shanghai Zhongshan Hospital
Phase 4
1,316
Hefei, Huizhou, Shenzhen, Harbin, Xinxiang, Wuhan, Changsha, Hengyang
2025-12-13
Active, closed
Guangzhou Patronus Biotech Co., Ltd.
Phase 2
840
Hengyang
2025-10-23
Recruiting
The Third Xiangya Hospital of Central South University
Phase 2
35
Changsha, Hengyang, Jishou
2025-08-29
Recruiting
Real World Evidence Study of SYN023 in Children Exposed to Rabies
NCT07327307Rabies Post-exposure Prophylaxis
Synermore Biologics (Suzhou) Co., Ltd.
Observational
232
Beijing, Shenzhen, Changsha, Hengyang, Nanchang
2025-08-02
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 3
450
Guangzhou, Hangzhou, Hengyang, Nanning, Shenzhen, Taiyuan, Tianjin, Zhengzhou
2025-05-19
Recruiting
The First Affiliated Hospital of University of South China
Observational
800
Hengyang
2025-05-16
Recruiting
Immunonutrition Reduces Acute Esophagitis After Thoracic Radiotherapy in Lung Cancer
NCT06840704Non Small Cell Lung Cancer, Small Cell Lung Cancer
Hunan Cancer Hospital
Phase 3
121
Changsha, Chenzhou, Hengyang, Yueyang
2025-02-25
Recruiting
AstraZeneca
Phase 3
240
Beijing, Chongqing, Dongguan, Guangzhou, Hangzhou, Hengyang, Jining, Nanjing
2024-06-20
Recruiting
Endovascular Treatment for eXtra-Large Ischemic Stroke
NCT06388148Stroke, Acute Ischemic
Zhongming Qiu
Not applicable
286
Hengyang, Xiangtan
2024-06-16
Recruiting
The First Affiliated Hospital of University of South China
Observational
712
Hengyang
2024-05-16
Active, closed
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1/2
80
Baotou, Beijing, Changsha, Chengdu, Chongqing, Fuyang, Guangzhou, Hengyang
2023-07-06
Not yet open
Nanfang Hospital, Southern Medical University
Observational
2,592
Fuzhou, Dongguan, Guangzhou, Heyuan, Huizhou, Haikou, Changsha, Hengyang
2023-07-01
Recruiting
Xiangya Hospital of Central South University
Observational
400
Guangzhou, Chenzhou, Hengyang
2023-05-25
Recruiting
Nanfang Hospital, Southern Medical University
Observational
2,592
Fuzhou, Dongguan, Guangzhou, Heyuan, Huizhou, Haikou, Changsha, Hengyang
2023-05-01
Recruiting
The First Affiliated Hospital of University of South China
Phase 4
312
Hengyang
2022-12-01
Recruiting
Nanfang Hospital, Southern Medical University
Not applicable
344
Quanzhou, Guangzhou, Shantou, Ganzhou, Changsha, Hengyang, Changchun, Shenyang
2022-09-01
Recruiting
Sun Yat-sen University
Phase 3
766
Chongqing, Guangzhou, Hengyang, Shenyang, Xi'an, Nanchong
2022-07-05
Active, closed
Cloudbreak Therapeutics, LLC
Phase 3
660
Beijing, Chengdu, Haikou, Hengyang, Kunming, Nanchang, Qingdao, Wenzhou
2022-06-30
Active, closed
Loxo Oncology, Inc.
Phase 3
600
Beijing, Changsha, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hefei, Hengyang
2021-09-20
Recruiting
Coronary Artery Calcification in Type 2 Diabetes Mellitus (USCAC Study)
NCT04889053Type 2 Diabetes, Vascular Calcification, Coronary Artery Calcification, Strains
University of South China
Observational
1,400
Hengyang
2021-06-01
Active, closed
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
NCT03653507Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
507
Fuzhou, Haikou, Zhengzhou, Changsha, Hengyang, Suzhou, Wuxi, Hangzhou
2018-11-28
Active, closed
Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients
NCT02221999Tubular Breast Cancer, Mucinous Breast Cancer, Invasive Ductal Breast Cancer, Inflammatory Breast Cancer
DrugsTaxol·Letrozole·Paclitaxel·Cisplatin
RenJi Hospital
Phase 2/3
250
Shenzhen, Handan, Hengyang, Hohhot, Kunshan, Yinchuan, Shanghai, Zhoushan
2013-09
Rows per page Showing 1–27 of 27
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/hengyang

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 27 of those studies with a site in Hengyang.

How many clinical trials are recruiting in Hengyang?

18 of the 27 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 3 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hengyang), 27 studies
PhaseStudiesRecruitingShare
Observational7625.9%
Phase 37425.9%
Phase 26322.2%
Not applicable3311.1%
Phase 4227.4%
Phase 1/2103.7%
Phase 2/3103.7%

Most active sponsors

Lead sponsors with the most studies (Hengyang)
Lead sponsorStudiesRecruiting
Nanfang Hospital, Southern Medical University32
The First Affiliated Hospital of University of South China33
AstraZeneca22
Eli Lilly and Company22
Alexion Pharmaceuticals, Inc.11
Astellas Pharma Global Development, Inc.10
Cloudbreak Therapeutics, LLC10
Guangzhou Patronus Biotech Co., Ltd.10
Hunan Cancer Hospital11
Loxo Oncology, Inc.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.